| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |